Immunitybio Inc

Immunitybio Inc

IBRX · NASDAQ
IBRX · NASDAQ
8.33
USD0.384.71%

Latest News

    @Reuters
    Reuters

    U.S. FDA approves ImmunityBio's bladder cancer therapy https://t.co/h6fCZI7LGc https://t.co/MrzE2mYkJJ

      @Reuters
      Reuters

      FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump https://t.co/4oSfsP5z2O https://t.co/jp9cGQFaRa

        @Reuters
        Reuters

        FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump https://t.co/OSTzcLo8Zk https://t.co/1WofQlZIyc

          @Reuters
          Reuters

          FDA declines to approve ImmunityBio's bladder cancer therapy, shares slump https://t.co/3ZJbaXPIpf https://t.co/mbTNqqVdND

            SeekingAlpha

            ImmunityBio in pact to acquire certain assets, leasehold interest from Athenex

            Analysts Recommendations

            Bullish

            Buy

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            8.15USD
            8.43USD

            52 Week Range

            1.95USD
            12.43USD

            Market Cap

            8.79BUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NASDAQ

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US45256X1037

            CUSIP

            45256X103

            Sector

            Healthcare

            Industry

            Biotechnology

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            -

            PEG Ratio

            -

            Book Value

            -0.99

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            -0.96

            Wall Street Target Price

            14.25

            EPS Estimate Current Year

            -0.92

            EPS Estimate Next Year

            -0.07

            EPS Estimate Current Quarter

            -0.08

            EPS Estimate Next Quarter

            -0.07

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            165,792,000

            Gross Profit TTM

            164,696,992

            EBITDA

            -235,298,000

            Profit Margin

            0.00%

            Return On Assets TTM

            -30.54%

            Return On Equity TTM

            0.00%

            Revenue Per Share TTM

            0.165

            Qtly Revenue Growth YOY

            93.90%

            Diluted Eps TTM

            -0.96

            Qtly Earnings Growth YOY

            0.00%

            Valuation

            Trailing PE

            0.00

            Forward PE

            82

            Price Sales TTM

            50.8209

            Price Book MRQ

            0

            Enterprise Value Revenue

            55

            Enterprise Value EBITDA

            -8

            Peers analysis

            • argenx NV ADR
              ARGXargenx NV ADR

              903.08

              3.20%
            • Moderna Inc
              MRNAModerna Inc

              227.40

              2.97%
            • Regeneron Pharmaceuticals Inc
              REGNRegeneron Pharmaceuticals Inc

              965.00

              0.55%
            • UCB SA
              UCBJFUCB SA

              314.92

              0.35%
            • argenx SE
              ARGNFargenx SE

              900.30

              0.00%
            • CSL Limited
              CMXHFCSL Limited

              139.16

              0.00%
            • Vertex Pharmaceuticals Inc
              VRTXVertex Pharmaceuticals Inc

              528.21

              -4.77%
            • Be
              ONCBeiGene, Ltd.

              355.10

              -2.26%
            • CSL Ltd
              CSLLYCSL Ltd

              34.64

              -2.01%
            • UCB SA ADR
              UCBJYUCB SA ADR

              153.70

              -1.47%

            FAQs

            What is Immunitybio stock price today?

            What is Immunitybio stock ticker?

            Is IBRX stock price going up?

            What is the analyst recommendation for IBRX?

            What is IBRX market cap?

            Does IBRX release financial reports?

            When is IBRX next earnings date?

            What were IBRX Earnings for the last quarter?

            What was IBRX Revenue for the last quarter?

            What was IBRX Net Income for the last quarter?

            Does IBRX pay dividends?

            How many employees does IBRX have?

            What is IBRX EBITDA?

            How to buy IBRX stocks?

            Should I invest in IBRX stock?